Patents by Inventor Ty R. Shockley

Ty R. Shockley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
    Patent number: 5965533
    Abstract: The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: October 12, 1999
    Assignees: Baxter International Inc., Miles G. Johnston
    Inventors: Chi J. Chen, Ty R. Shockley, Miles G. Johnston
  • Low sodium peritoneal dialysis solution
    Patent number: 5631025
    Abstract: An improved peritoneal dialysis solution and methods of administering same to a patient are provided. Pursuant to the present invention, the sodium concentration in the solution is decreased thus causing sodium to be transported from the circulation to the peritoneal cavity. This provides for an improved ultrafiltration profile for the same initial osmolality when compared to standard solutions. Also, the same ultrafiltration profile as standard solutions can be achieved with lower initial osmolalities.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: May 20, 1997
    Assignee: Baxter International Inc.
    Inventors: Ty R. Shockley, Leo Martis, Lee W. Henderson, John Moran, Masaaki Nakayama
  • Low sodium peritoneal dialysis solution
    Patent number: 5629025
    Abstract: An improved peritoneal dialysis solution comprising an osmotic agent having at least one amino acid, and a method of administering same to a patient are provided. Pursuant to the present invention, the sodium concentration in the solution is decreased thus causing sodium to be transported from the circulation to the peritoneal cavity. This provides for an improved ultrafiltration profile that is, more volume over a longer period of time, for the same initial osmolality when compared to standard solutions. Also, the same ultrafiltration profile as standard solutions can be achieved with lower initial osmolalities.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: May 13, 1997
    Assignee: Baxter International Inc.
    Inventors: Ty R. Shockley, Leo Martis, Lee W. Henderson, John Moran, Masaaki Nakayama
  • Low sodium peritoneal dialysis solution
    Patent number: 5589197
    Abstract: A peritoneal dialysis solution and method of administering same to a patient are provided wherein the sodium concentration in the solution is decreased thus causing sodium to be transported from the circulation to the peritoneal cavity. This provides for an improved ultrafiltration profile (more volume over a longer period of time) for the same initial osmolality when compared to standard solutions. Also, the same ultrafiltration profile as standard solutions can be achieved with lower initial osmolalities. A reduced amount of osmotic agent can be used to achieve equivalent ultrafiltration.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: December 31, 1996
    Assignee: Baxter International, Inc.
    Inventors: Ty R. Shockley, Leo Martis, Lee W. Henderson, John Moran, Masaaki Nakayama